- Hippo Holdings Inc. (NYSE:HIPO) Board has authorized a stock repurchase program for up to $50 million of its common stock, effective immediately.
- Repurchases under the program may be made in the open market, in privately negotiated transactions, or otherwise.
- The program does not obligate Hippo to acquire any particular amount of its common stock and may be modified, suspended, or terminated at any time at Hippo’s discretion.
- HIPO held cash and investments of $640 million at year-end.
- Price Action: HIPO shares are trading higher by 7.72% at $14.23 on the last check Monday.
Reported Late Tuesday, Mesoblast Announces Top-Line Long-Term Survival Results For Remestemcel-L From Its Pivotal Phase 3 Trial Through 4-Years In Children With Steroid-Refractory Acute Graft vs Host Disease
Long-term survival evident through 4 years in children treated with remestemcel-L in Phase 3 trial MSB-GVHD001
Overall survival at 2 years was 51% in remestemcel-L treated children and 25-38% in
